权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Tissue-Targeted Enzyme for Localized Tryptophan Catabolism to Direct Subcutaneous and Oral Mucosal Inflammatory Responses

用于局部色氨酸分解代谢的组织靶向酶以指导皮下和口腔粘膜炎症反应

基本信息

批准号：
9752509
负责人：
Benjamin George Keselowsky
金额：
$ 46.42万
依托单位：
UNIVERSITY OF FLORIDA
依托单位国家：
美国
项目类别：
财政年份：
2017
资助国家：
美国
起止时间：
2017-08-01 至 2021-07-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/9752509
关键词：
Affinity Apoptosis Area Autoimmunity Avidity Binding Bone Resorption Carbohydrates Catabolism Cell physiology Cellular Metabolic Process Chimera organism Chimeric Proteins Chronic Consumption Data Dioxygenases Disease Environment Enzymes Essential Amino Acids Extracellular Matrix Family Galectin 3 Goals Homeostasis Immune Immune system Immunosuppressive Agents Immunotherapy In Vitro Individual Inflammation Inflammatory Inflammatory Response Investigation Kynurenine Lectin Leukocytes Lipopolysaccharides Luciferases Maintenance Mediating Metabolic Modeling Oral Oral mucous membrane structure Osteoclasts Pathway interactions Peptides Periodontal Diseases Pregnancy Process Production Regulatory T-Lymphocyte Surface T cell anergy T cell response T-Lymphocyte Technology Time Tissues Tooth Loss Treatment Efficacy Tryptophan Tryptophan Metabolism Pathway cancer therapy carbohydrate binding protein design effector T cell efficacy testing in vivo indoleamine innovation lactosamine member novel strategies overexpression programs response self assembly soft tissue subcutaneous transplant model

项目摘要

Project Summary/Abstract There is a considerable need for targeted technologies that direct the immune system for the controlled suppression of localized inflammation. Programming immune cell metabolism is a new and active area of investigation with numerous diverse immunotherapy applications. We are developing an innovative new approach of locally administering a tissue-targeted chimeric enzyme which catabolize the essential amino acid, tryptophan, and produces kynurenines, together inducing a powerful immunosuppressive metabolic programming. The chosen tissue targeting domain confers prolonged tissue retention, and the enzymatic activity can block local inflammation for an extended time. We are applying this technology for the amelioration of periodontal disease, in which localized non-resolving chronic inflammation is associated with a shift away from a submucosal environment rich in tolerance toward one of inflammation consisting of Th1 and Th17 T cells at the expense of regulatory T cells.

项目摘要/摘要有相当大的需求有针对性的技术，以指导免疫系统为对局部炎症有控制的抑制。编程免疫细胞新陈代谢是一种新的和活跃的研究领域，拥有众多不同的免疫疗法应用。我们是开发一种局部给药组织靶向嵌合体的创新方法分解必需氨基酸色氨酸并产生犬尿氨酸的酶，共同诱导一种强大的免疫抑制代谢程序。选定的组织靶向结构域可延长组织滞留时间，酶活性可阻断局部长期发炎。我们正在应用这项技术来改进牙周病，在这种疾病中，局部的未消退的慢性炎症与从充满耐受性的粘膜下环境转向由炎症组成的环境以牺牲调节性T细胞为代价的Th1和Th17T细胞。